Medicus Pharma Stock Shares Owned By Institutions
| MDCX Stock | 3.95 0.25 6.76% |
Medicus Pharma fundamentals help investors to digest information that contributes to Medicus Pharma's financial success or failures. It also enables traders to predict the movement of Medicus Stock. The fundamental analysis module provides a way to measure Medicus Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicus Pharma stock.
Medicus |
Medicus Pharma Company Shares Owned By Institutions Analysis
Medicus Pharma's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.0% of Medicus Pharma are shares owned by institutions. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Shares Owned By Institutions (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Medicus Fundamentals
| Current Valuation | 39.63 M | |||
| Shares Outstanding | 11.82 M | |||
| Number Of Shares Shorted | 900 | |||
| Price To Book | 9.40 X | |||
| Net Income | (6.78 M) | |||
| Total Debt | 1.09 M | |||
| Cash Flow From Operations | (4.16 M) | |||
| Short Ratio | 0.96 X | |||
| Earnings Per Share | (1.25) X | |||
| Target Price | 5.61 | |||
| Market Capitalization | 46.68 M | |||
| Total Asset | 1.89 M | |||
| Retained Earnings | (19.18 M) | |||
| Working Capital | 805.8 K | |||
| Net Asset | 1.89 M |
About Medicus Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.